Table 1.
Comparison of background characteristics between the groups with and without statins (N = 200)
| Clinical variables | Statin intake (n = 47) | Without statin intake (n = 153) | P-value |
|---|---|---|---|
| Age | 72 (47-90) | 67 (36-86) | 0.010 |
| Gender (Male) | 25 (53%) | 83 (54%) | 0.515 |
| CEA (ng/nL) | 3.0 (0.5-112) | 2.5 (0.2-39.3) | 0.276 |
| CA19-9 (U/L) | 47.5 (0.5-2200) | 64.0 (0.1-4764) | 0.169 |
| Blood loss (g) | 639 (45-13153) | 646 (10-12925) | 0.672 |
| Operation time (min) | 483 (120-791) | 494 (150-1221) | 0.079 |
| T-stage (T3, T4) | 41 (87%) | 129 (84%) | 0.410 |
| Lymph node positive, | 22 (47%) | 85 (56%) | 0.188 |
| Morbidity (CDCs > III) | 13 (28%) | 43 (28%) | 0.556 |
| Adjuvant chemotherapy | 38 (81%) | 126 (82%) | 0.483 |
CDCs, Clavien-Dindo classifications. The T stage was used by the UICC for International Cancer Control 7th edition.